Assessing H. pylori infection rates and antibiotic resistance in Germany

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the prevalence of Helicobacter pylori infections and the rates of antibiotic resistance in Germany. It involves screening volunteers for H. pylori infection through serology, followed by confirmation via breath tests and long-term observation for those who test positive. Patients undergoing endoscopy will have biopsies taken to analyze antibiotic resistance, and a biobank will be established for further molecular analysis. The study seeks to provide essential data for effective treatment regimens based on local resistance patterns.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Minimum age of 18 years
* informed consent for HelicoPTER study
* informed consent for HEPY biobank

Exclusion Criteria:

* no capacity to consent

Where it's running

• Department of Medicine II, University Hospital of Munich
  Munich, Germany Recruiting

Study contacts

• Principal investigator: Markus Gerhard, Prof. — Technical University of Munich
• Study coordinator: Markus Gerhard, Prof.
• Email: markus.gerhard@tum.de
• Phone: +49894140

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adding Saccharomyces boulardii to bismuth quadruple therapy for H. pylori rescue

  This tests whether adding the probiotic Saccharomyces boulardii to bismuth-containing quadruple therapy helps adults whose H. pylori infection did not clear after prior treatments.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07139366

• AI-guided health recommendations for gastric cancer prevention

  This study is testing an AI tool that helps doctors spot early signs of stomach issues and gives personalized advice to prevent gastric cancer.

  Recruiting Fundación para la Investigación del Hospital Clínico de Valencia · Valencia · NCT06421324

• Using broad-spectrum antibiotics to prevent infections in orthopedic surgery

  This study tests whether using a stronger type of antibiotics before orthopedic surgery can help prevent infections in patients who are at high risk.

  Recruiting Phase 3 Balgrist University Hospital · Zurich · NCT05502380

• Observational study on gastric precancerous conditions

  This study looks at people who are at higher risk for stomach cancer to see how conditions like atrophic gastritis and intestinal metaplasia develop over time.

  Recruiting Stanford University · Stanford, California · NCT04191551

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Neoadjuvant trastuzumab, durvalumab, and FLOT for HER2-positive gastric or GEJ cancer

  This study tests a pre-surgery treatment combining trastuzumab, durvalumab, and FLOT for patients with HER2-positive locally advanced gastric or gastroesophageal junction cancer to see how many achieve complete tumor disappearance.

  Recruiting Phase 2 Samsung Medical Center · Seoul, Gang-Nam · NCT07911280

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.